Stock screener

NUVB

Conviction 37HealthcareScan · Thu, Sep 24, 2026
Dragonfly doji

Nuvation Bio Inc. (NUVB) closed at $5.72 (+0.09%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day and below its 200-day moving average. RSI(14) 38, RS Rating 98, -40.1% from its 52-week high, -33.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

NUVB$5.72+0.09%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 5.13M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Nuvation Bio Inc.PHARMACEUTICAL PREPARATIONSwww.nuvationbio.com ↗
Price5.72
Change+0.09%
Gap+0.26%
Rel volume1.87×
Avg volume4.87M
Avg $ vol30.32M
SMA 206.30
SMA 506.42
SMA 2005.86
Price vs 50-11.04%
Price vs 200-2.46%
MA stackmixed
50/200 cross—
Supertrenddown · 6.62
RSI (14)38
MACD hist-0.07
MACD cross—
Stoch %K / %D13 / 17
ADX (14)17
+DI / −DI18 / 30
RSI divergence—
MACD divergence—
ATR %5.76%
ADR %4.71%
52w high9.54
52w low3.01
From 52w high-40.09%
Above 52w low+89.87%
New 52w highNo
SqueezeOff
Bollinger width27.00%
%B0.16
Donchian pos10.67%
Donchian high7.18
Donchian low5.54
AVWAP (52w high)5.80
vs AVWAP high-1.53%
AVWAP (52w low)5.74
vs AVWAP low-0.52%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d1.87×
Avg vol (14d)5.13M
Avg vol (20d)4.87M
Avg $ vol (20d)30.32M
Market cap2.01B
RS Rating98 / 99
RS 3m (vs SPY)-6.13%
RS 6m (vs SPY)+13.66%
RS line new highNo
Trend template1/8
Technical rank45.3
1 week-5.85%
1 month-19.51%
3 months-1.64%
6 months+30.48%
1 year+77.48%
YTD-33.39%
P/E-9.81
P/B7.90
P/S31.90
P/FCF—
EPS-0.6000
Div yield—
ROE-80.61%
ROA-27.48%
Debt/Eq0.98
Current8.37
EV/EBITDA-9.45
Gross margin1.26%
Net margin-325.31%
Rev growth698.96%
EPS growth63.97%
Price target15.00
Target upside162.47%
Analyst ratingBuy
Institutional71.32%
Ent. value2B
Revenue31.69M
Net income-62.84M
Gross profit9.77M
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out348.2M
Employees307
ListedWed, Feb 10, 2021
Free float236.38M
Float %69.0%
Short interest54.26M
Days to cover10.7d
Short volume50.7%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.15 vs −$0.15
Last surprise0.0% beat
Setup gradeD
Conviction37 / 100
Pattern quality—
Tech rank45.3 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NUVB

All disclosures →
No recent disclosed trades by Congress in NUVB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NUVB · open-market 1 sell

InsiderSideShares
Hattersley Gary
CHIEF SCIENTIFIC OFFICER · Class A Common Stock · 2026-08-19
Exercise100K
Hattersley Gary
CHIEF SCIENTIFIC OFFICER · Stock Option (Right to Buy) · 2026-08-19
Exercise100K
Hattersley Gary
CHIEF SCIENTIFIC OFFICER · Class A Common Stock · 2026-08-19
Sell100K
Sauvage Philippe
Chief Financial Officer · Stock Option (Right to Buy) · 2026-07-15
Exercise1
Sauvage Philippe
Chief Financial Officer · Class A Common Stock · 2026-07-15
Exercise1
Sauvage Philippe
Chief Financial Officer · Stock Option (Right to Buy) · 2026-07-15
Exercise40K
Sauvage Philippe
Chief Financial Officer · Class A Common Stock · 2026-07-15
Exercise40K
Bazemore Robert B
Director · Stock Option (Right to Buy) · 2026-05-21
Grant123.4K
BLICKENSTAFF KIM D
Director · Stock Option (Right to Buy) · 2026-05-21
Grant123.4K
Mashal Robert
Director · Stock Option (Right to Buy) · 2026-05-21
Grant123.4K

SEC filings

EDGAR filings in NUVB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.